Results 11 to 20 of about 105,016 (295)
PLA2R-positive membranous nephropathy in IgG4-related disease
BMC NephrologyBackground IgG4-related disease (IgG4-RD) is a fibroinflammatory disease that affects multiple organs, including the pancreas, lacrimal glands, salivary glands, periaortic/retroperitoneum, and kidney.
Yusuke Ushio +13 more
doaj +2 more sources
Membranous glomerulopathy and treatment with Acthar®: a case study
International Journal of Nephrology and Renovascular Disease, 2013 Myra June WatsonNephrology/Hypertension Associates, Columbia, MO, USAAbstract: Treatment options for refractory membranous nephropathy are limited. Herein we describe the case of a 46-year-old white male with membranous nephropathy who progressed during ...
Watson MJ
doaj +1 more source
Kidney International ReportsIntroduction: Membranous nephropathy can lead to end-stage kidney disease, for which kidney transplantation is the preferred therapy. However, the disease often relapses, which can impact allograft survival.
Marion Cremoni +35 more
doaj +2 more sources
Advances in Membranous Nephropathy [PDF]
Journal of Clinical Medicine, 2021 Membranous nephropathy (MN) is a rare auto-immune disease where the glomerulus is targeted by circulating auto-antibodies mostly against podocyte antigens, which results in the formation of electron-dense immune complexes, activation of complement and massive proteinuria.
Ronco, Pierre +2 more
openaire +3 more sources
Update on New Antigens in the Pathogenesis of Membranous Nephropathy [PDF]
, 2022 Previously, membranous nephropathies were divided into primary and secondary categories when the exact mechanism or pathogenetic factor were unknown. Approximately 70% accounted for primary membranous nephropathies.
Aris Tsalouchos, Maurizio Salvadori
core +1 more source
Kidney Medicine, 2021 Technological advances have allowed the discovery of 6 subtypes of membranous nephropathy based on target antigens: M-type phospholipase A2 receptor (PLA2R), thrombospondin type 1 domain-containing 7A (THSD7A), neural epidermal growth factor-like 1 ...
Takamasa Iwakura +7 more
doaj +1 more source
Journal of the Royal College of Physicians of London, 1997 link_to_subscribed_fulltext
Simon C Satchell, Peter W Mathieson
openaire +4 more sources
The Efficacy of Rituximab in the Treatment of Membranous Nephropathy
Journal of Nepal Health Research Council, 2021 Rituximab is a chimeric monoclonal antibody directed against the CD20 expressed on B cells, originally used to treat lymphoma but is increasingly used for the treatment of autoimmune diseases.
Ruby Maharjan +2 more
doaj +1 more source
Treatment of membranous nephropathy [PDF]
Nephrology Dialysis Transplantation, 2001 Several therapeutic approaches have been tried in patients with membranous nephropathy. Corticosteroids have been largely used, but a meta-analysis of the available controlled trials did not show any benefit of corticosteroids either in favouring remission of the nephrotic syndrome or in preventing renal dysfunction.
Passerini Patrizia, Ponticelli Claudio
openaire +4 more sources
Lupus Membranous Nephropathy [PDF]
Glomerular Diseases, 2021 <b><i>Background:</i></b> Lupus membranous nephropathy (LMN) is a rare disease, usually associated with nephrotic syndrome. <b><i>Methods:</i></b> We reviewed the literature by searching for the following terms on Pubmed.gov: lupus nephritis, membranous nephropathy (MN), lupus membranous nephropathy ...
Ponticelli, Claudio +2 more
openaire +2 more sources